12:00 AM
 | 
Sep 10, 2012
 |  BC Week In Review  |  Company News  |  Deals

Astex Pharmaceuticals, Cancer Research U.K., Institute of Cancer Research deal

Astex, the institute and Cancer Research U.K.'s commercial subsidiary Cancer Research Technology (CRT) Ltd. partnered to discover and develop oral therapies against an undisclosed epigenetic target...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >